Influenza B virus (ATCC® VR-790)

Classification: Orthomyxoviridae, Influenzavirus B  /  Product Format: frozen

Classification Orthomyxoviridae, Influenzavirus B
Agent Influenza B virus
Strain B/Russia/69
Applications
Influenza Research
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Influenza patient
Product Format frozen
Storage Conditions -70°C or colder
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Effect on Host
Tumorigenicity, hemagglutination activity
 Hemagglutination of Chicken RBC’s
Recommended Host
chicken embryo

Recommended Host:  SPF CE (10 to 11 day old, intra allantoic)

Growth Conditions
Temperature: 37.0°C
Duration: 1-4 days
Effect on Host
Tumorigenicity, hemagglutination activity
 Hemagglutination of Chicken RBC’s
Name of Depositor R.I.T. - Recherche et Industrie Therapeutiques
U.S. Patent
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Source
Influenza patient
References

Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976

Smorodintsev A. The efficacy of live influenza vaccines. Bull. World Health Organ. 41: 585-588, 1969. PubMed: 5309480